Menopause (New York, N.Y.)

Menopause · ISSN (e) 1530-0374 · 80 papers in corpus
diagnostic-accuracy 2015
doi:10.1097/GME.0000000000000358 ·PMID:25535964

OBJECTIVE: This study aims to evaluate the diagnostic efficiency of pattern recognition by transvaginal ultrasonography (TVS) and gel infusion sonography (GIS) for identifying endometrial pathology and to compare this setup with a standard …

observational 2015
doi:10.1097/gme.0000000000000411 ·PMID:25647777

OBJECTIVE: This study aims to examine whether gynecologic conditions are associated with chronic fatigue syndrome (CFS). METHODS: This study includes a subset of 157 women from a population-based case-control study in Georgia, United State…

review 2015
doi:10.1097/gme.0000000000000365 ·PMID:25423325

OBJECTIVE: Treatment of menopausal symptoms by compounds with tissue-selective estrogen agonist/antagonist effects, often called selective estrogen receptor modulators, has been researched as an alternative to the use of estrogen therapy. T…

observational 2015
doi:10.1097/gme.0000000000000445 ·PMID:25756693

OBJECTIVE: This study aims to analyze long-term variation in bone mineral density among young women with primary ovarian insufficiency. METHODS: A cohort study evaluated bone mineral density in 72 women with primary ovarian insufficiency w…

other 2015
doi:10.1097/gme.0000000000000427 ·PMID:25692878

Department of Obstetrics and Gynecology Midlife Health Center University of Virginia Charlottesville, Virginia

observational 2015
doi:10.1097/gme.0000000000000417 ·PMID:25628058

OBJECTIVE: This study aimed to translate the Utian Quality of Life Scale (UQOL) into the Serbian and to assess its validity and psychometric properties in Serbian peri- and postmenopausal women. METHODS: This survey included 200 perimenopa…

observational 2014
doi:10.1097/gme.0000000000000286 ·PMID:25003622

OBJECTIVE: This study aims to describe premature ovarian failure (POF)/primary ovarian insufficiency (POI) symptoms experienced by women from a non-clinic-based sample of members of a POF/POI-specific support group. METHODS: Two hundred ni…

other 2014
doi:10.1097/gme.0000000000000246 ·PMID:24755899

Department of Obstetrics and Gynecology Baystate Medical Center Tufts University School of Medicine Springfield, Massachusetts

observational 2013
doi:10.1097/gme.0b013e3182a3ff45 ·PMID:24067261

OBJECTIVE: Unilateral oophorectomy (UO) is a common surgical practice, yet it remains understudied. We investigated trends in incidence rates, indications, and pathological differences in the right and left ovaries in women younger than 50 …

observational 2013
doi:10.1097/gme.0b013e31829fc376 ·PMID:23942250

OBJECTIVE: This study aims to assess obstetrician-gynecologists' opinions on elective bilateral oophorectomy (BO) at the time of hysterectomy in the United States and to describe factors that influence their views. METHODS: In April 2012, …

other 2012
doi:10.1097/gme.0b013e3182651d8d ·PMID:22922510

Menopause: The Journal of The North American Menopause Society 19(9):p 949-951, September 2012. | DOI: 10.1097/gme.0b013e3182651d8d

other 2012
doi:10.1097/gme.0b013e31824f5cbb ·PMID:22588212

Menopause: June 2012 - Volume 19 - Issue 6 - p 604-605 doi: 10.1097/gme.0b013e31824f5cbb

guideline 2012
doi:10.1097/gme.0b013e31824b970a ·PMID:22367731

OBJECTIVE: This position statement aimed to update the evidence-based position statement published by The North American Menopause Society (NAMS) in 2010 regarding recommendations for hormone therapy (HT) for postmenopausal women. This upda…

review 2011
doi:10.1097/gme.0b013e31820ca808 ·PMID:21701426

The aim of this study was to present a review of the potential mechanisms involved in the occurrence of endometrial bleeding in postmenopausal women using hormone therapy. Selected literature on the incidence of bleeding in postmenopausal w…

review 2011
doi:10.1097/gme.0b013e3182127b53 ·PMID:21701433

New therapies for abnormal uterine bleeding have been slow to reach the marketplace for a variety of reasons. These reasons include the availability of cost-effective therapies already available and the extraordinarily difficult and expensi…

rct 2011
doi:10.1097/gme.0b013e318223bbf4 ·PMID:21993078

OBJECTIVE: The aim of this study was to report the gynecologic safety findings from the Generations trial, a phase 3 study of the selective estrogen receptor modulator (SERM), arzoxifene. METHODS: A predefined objective of the trial was to…

review 2011
doi:10.1097/gme.0b013e31820bf288 ·PMID:21499503

Expression of tissue factor (TF), the primary initiator of coagulation, is enhanced in decidualized human endometrial stromal cells (HESC) during the progesterone-dominated luteal phase. Progesterone also augments a second HESC hemostatic f…

observational 2011
doi:10.1097/gme.0b013e3181f9fa35 ·PMID:21228728

OBJECTIVE: Cross-sectional studies suggest an association between hysterectomy and negative affect. Using prospective data, we examined the associations of negative affect, attitudes toward aging and menopause, premenstrual symptoms, and va…

review 2011
doi:10.1097/gme.0b013e318212499c ·PMID:21701432

Pharmacological therapies for the treatment of abnormal uterine bleeding are effective and generally well tolerated. This review presents an evidence-based approach to medical therapy. Selection depends on the etiology and amount of bleedin…

other 2011
doi:10.1097/gme.0b013e31821bfc6e ·PMID:21587089

1Department of ObGyn and Internal Medicine The Reading Hospital and Medical Center Reading, Pennsylvania Department of ObGyn and Internal Medicine Jefferson Medical College of Thomas Jefferson University Philadelphia, Pennsylvania 2Departme…

review 2010
doi:10.1097/gme.0b013e3181df4a19 ·PMID:20616674

OBJECTIVE: There are significant individual differences in the extent to which mood and cognition change as a function of reproductive stage, menstrual phase, postpartum, and hormone therapy use. This review explores the extent to which var…

rct 2010
doi:10.1097/gme.0b013e3181d273c7 ·PMID:20386344

OBJECTIVE: We investigated the effects of dienogest (DNG), which has a profile similar to that of natural progesterone (P4), on the favorable effects of estrogen in endothelial function. METHODS: (1) Human umbilical vein endothelial cells …

other 2010
doi:10.1097/gme.0b013e3181c17c06 ·PMID:20061892

Vincent Obstetrics and Gynecology Service, Massachusetts General Hospital, Boston, MA Financial disclosure/conflicts of interest: None reported.

observational 2009
doi:10.1097/gme.0b013e31818888f7 ·PMID:19034050

OBJECTIVE: To investigate the mortality associated with cardiovascular diseases and the effect of estrogen treatment in women who underwent unilateral or bilateral oophorectomy before menopause. DESIGN: We conducted a cohort study with lon…

review 2009
doi:10.1097/gme.0b013e3181924701 ·PMID:19131842

Department of Obstetrics and Gynecology, George Washington University School of Medicine, Women's Health & Research Consultants®, Washington, DC Financial disclosure: Dr Simon has served as a consultant or on the advisory boards of Allergan…